God, AIDS, Africa & HOPE

Reflections / Gedanken

There is always a trace of hope in science


hiv virionVorinostat, a chemotherapeutic drug which inhibits histone deacetylase and is used mainly to treat refractory T-cell lymphomas under the brand name Zolinza, has been found to awaken quiescent cells infected with HIV thus creating an avenue by which the infection may be cured completely.

A single dose of the drug (which is marketed by Merck) was able to reactivate such cells in the study that was conducted in the University of North Carolina, USA.

This study has aroused tremendous interest in the field of HIV/AIDS as current drug regimens only suppress the viral load to undetectable levels; stopping the medication usually leads to a relapse of the disease with the very significant risk of drug resistance.

Merck’s head of research Daria Hazuda doesn’t think that Zolinza itself would be the drug that would be used in this form of aggressive therapy, but rather a prototype that would pave…

View original post 42 more words

Filed under: HIV Treatment, Medical and Research, , , , , , , ,

Blog Categories

Follow God, AIDS, Africa & HOPE on WordPress.com

You can share this blog in many ways..

Bookmark and Share

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 4,135 other subscribers

Translation – Deutsch? Française? Espanol? …

The translation button is located on each single blog page, Copy the text, click the button and paste it for instant translation:
Website Translation Widget

or for the translation of the front page:

* Click for Translation


© Rev Fr Stefan Hippler and HIV, AIDS and HOPE.
Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Rev Fr Stefan Hippler and HIV, AIDS and HOPE with appropriate and specific direction to the original content.

This not withstanding the following applies:
Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 3.0 Unported License.

%d bloggers like this: